Analytical Data
-
Gene name
OAF
-
简介
OAF proteins are important members of the OAF family and play critical but not yet fully elucidated roles in cellular processes. As part of this family, OAFs contribute to intracellular functions and are continually being explored for their specific functions. OAF Protein, Human (HEK293, His) is the recombinant human-derived OAF protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
Alternative Names
Out at first protein homolog; OAF; NS5ATP13TP2
-
Species
Human
-
Source
HEK293
-
Tag
C-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86UD1
-
Expression Region
A28-G273
-
Protein Length
Full Length of Mature Protein
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OAF (Octacosanol-Associated Factor) recombinant protein research focuses on understanding the role of this protein in various biological processes and its potential applications in biotechnology and medicine. OAF is known to be involved in the regulation of gene expression and metabolic pathways, particularly those related to lipid metabolism and energy homeostasis. The emergence of recombinant DNA technology has enabled scientists to produce OAF in a controlled environment, allowing for detailed characterization of its structure and function. This protein's significance is further underscored by its potential therapeutic applications; for instance, studies suggest that it may play a role in treating metabolic disorders, obesity, and other health issues linked to lipid imbalance. The ability to produce OAF recombinantly provides researchers with a valuable tool for investigating its biological effects, exploring its mechanisms of action, and potentially developing novel interventions. Overall, the study of OAF and its recombinant variants holds promise for advancing our understanding of metabolic regulation and improving health outcomes through targeted therapies.
